INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q4 2021. The put-call ratio across all filers is 6.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $39,553,000 | -48.3% | 1,454,164 | -67.5% | 0.05% | -47.3% |
| Q2 2021 | $76,462,000 | -2.8% | 4,474,081 | +18.7% | 0.09% | -8.1% |
| Q1 2021 | $78,679,000 | +15.8% | 3,768,171 | +27.0% | 0.10% | +19.3% |
| Q4 2020 | $67,932,000 | +116.1% | 2,966,448 | +53.9% | 0.08% | +88.6% |
| Q3 2020 | $31,430,000 | +55.1% | 1,927,010 | +28.8% | 0.04% | +37.5% |
| Q2 2020 | $20,262,000 | +40.5% | 1,496,474 | +23.0% | 0.03% | +3.2% |
| Q1 2020 | $14,421,000 | -28.7% | 1,216,961 | +49.7% | 0.03% | -11.4% |
| Q4 2019 | $20,237,000 | +119.1% | 812,720 | +49.7% | 0.04% | +105.9% |
| Q3 2019 | $9,237,000 | +11.4% | 543,054 | +49.1% | 0.02% | +13.3% |
| Q2 2019 | $8,292,000 | +16.4% | 364,330 | +64.5% | 0.02% | +7.1% |
| Q1 2019 | $7,121,000 | +78.7% | 221,505 | +56.7% | 0.01% | +55.6% |
| Q4 2018 | $3,984,000 | – | 141,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |